|
|
Post by bill on Jan 14, 2020 11:51:51 GMT -5
- A technically superior solution to an important problem
- Easy to use
- Reduces the likelihood of suffering severe health consequences during an adverse incident
- Difficult to convince users and authorities of the value proposition
- Years before wide-spread adoption
- Strong advocacy by a vocal minority
- Eventually achieves widespread adoption (we hope
 )
|
|
|
|
Post by mannmade on Jan 14, 2020 13:05:35 GMT -5
Unfortunately seatbelts were mandated under federal law so they had to become ubiquitous and used by 100% of drivers. I don't see that happening with Afrezza.
|
|
|
|
Post by cjm18 on Jan 14, 2020 16:09:52 GMT -5
Sounds like the keto diet.
|
|
|
|
Post by georgethenight2 on Jan 15, 2020 3:01:07 GMT -5
Yes. Mandated in 1968. However, invented and used much earlier. If you use this as an analogy for Afrezza. It is currently available and users find it leaps and bounds better than injectable mealtime insulin, yet until it becomes the SOC, we will drift along. But have no doubt, this drug will dominate the mealtime market. Diabetics want to live normal non-diabetic lives, Afrezza practically allows this to be a reality. As seat belts allow crash accident victims a great chance of survival when used properly. It is coming.
|
|
|
|
Post by uvula on Jan 15, 2020 9:49:15 GMT -5
I've never met anyone who claimed they made a fortune by being an early investor in a seat belt company.
|
|
|
|
Post by slugworth008 on Jan 15, 2020 11:33:55 GMT -5
And most longs so far haven't made anything being early investors in MNKD. Hopefully 2020 makes a dent in that.
|
|
|
|
Post by ktim on Jan 15, 2020 18:20:35 GMT -5
If we could just get NTSB to mandate each car seat have an emergency supply of meal time insulin. Would make trips to the drive through less hazardous.
|
|
)
